GRFS
Price
$7.45
Change
-$0.05 (-0.67%)
Updated
Oct 22 closing price
Capitalization
5.07B
19 days until earnings call
Intraday BUY SELL Signals
SNY
Price
$41.96
Change
+$0.99 (+2.42%)
Updated
Oct 22 closing price
Capitalization
100.54B
8 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GRFS vs SNY

GRFS vs SNY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GRFS vs. SNY commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRFS is a Hold and SNY is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GRFS with price predictions
Oct 22, 2026

GRFS's RSI Oscillator recovers from oversold territory

The RSI Oscillator for GRFS moved out of oversold territory on September 24, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 22 of the 31 cases the stock moved higher. This puts the odds of a move higher at 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on GRFS as a result. In 58 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for GRFS just turned positive on October 02, 2026. Looking at past instances where GRFS's MACD turned positive, the stock continued to rise in 26 of 46 cases over the following month. The odds of a continued upward trend are 57%.

Following a +5.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where GRFS advanced for three days, in 190 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 64 cases where GRFS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.

GRFS moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GRFS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

GRFS broke above its upper Bollinger Band on October 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GRFS entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.914) is normal, around the industry mean (-3.019). P/E Ratio (11.288) is within average values for comparable stocks, (21.251). Projected Growth (PEG Ratio) (0.189) is also within normal values, averaging (5.738). Dividend Yield (0.047) settles around the average of (0.041) among similar stocks. GRFS's P/S Ratio (0.592) is slightly lower than the industry average of (4.033).

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. GRFS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GRFS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock worse than average.

A.I.Advisor
a Summary for SNY with price predictions
Oct 22, 2026

SNY's RSI Oscillator ascending out of oversold territory

The RSI Indicator for SNY moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 19 of the 27 cases the stock moved higher. This puts the odds of a move higher at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on SNY as a result. In 61 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

The Moving Average Convergence Divergence (MACD) for SNY just turned positive on October 15, 2026. Looking at past instances where SNY's MACD turned positive, the stock continued to rise in 23 of 48 cases over the following month. The odds of a continued upward trend are 48%.

Following a +2.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNY advanced for three days, in 156 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

SNY broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SNY entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. SNY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.453) is normal, around the industry mean (-3.019). P/E Ratio (25.508) is within average values for comparable stocks, (21.251). SNY's Projected Growth (PEG Ratio) (27.976) is very high in comparison to the industry average of (5.738). SNY's Dividend Yield (0.189) is considerably higher than the industry average of (0.041). P/S Ratio (1.829) is also within normal values, averaging (4.033).

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock worse than average.

FUNDAMENTALS RATINGS
GRFS vs SNY: Fundamental Ratings
GRFS
SNY
OUTLOOK RATING
1..100
2414
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
7681
PRICE GROWTH RATING
1..100
5869
P/E GROWTH RATING
1..100
838
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRFS's Valuation (9) in the Pharmaceuticals Major industry is significantly better than the same rating for SNY (77). This means that GRFS’s stock grew significantly faster than SNY’s over the last 12 months.

SNY's Profit vs Risk Rating (87) in the Pharmaceuticals Major industry is in the same range as GRFS (100). This means that SNY’s stock grew similarly to GRFS’s over the last 12 months.

GRFS's SMR Rating (76) in the Pharmaceuticals Major industry is in the same range as SNY (81). This means that GRFS’s stock grew similarly to SNY’s over the last 12 months.

GRFS's Price Growth Rating (58) in the Pharmaceuticals Major industry is in the same range as SNY (69). This means that GRFS’s stock grew similarly to SNY’s over the last 12 months.

SNY's P/E Growth Rating (8) in the Pharmaceuticals Major industry is significantly better than the same rating for GRFS (83). This means that SNY’s stock grew significantly faster than GRFS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRFSSNY
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
49%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 7 days ago
69%
Bullish Trend 7 days ago
51%
Declines
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 10 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
57%
Aroon
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
52%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (GRFS: $7.50 vs. SNY: $40.97)
Brand notoriety: GRFS and SNY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GRFS: 66% vs. SNY: 104%
Market capitalization -- GRFS: $5.07B vs. SNY: $100.54B
GRFS [@Pharmaceuticals: Major] is valued at $5.07B. SNY’s [@Pharmaceuticals: Major] market capitalization is $100.54B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $4.8K to $1.13T. The average market capitalization across the [@Pharmaceuticals: Major] industry is $206.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRFS’s FA Score shows that 1 FA rating(s) are green while SNY’s FA Score has 1 green FA rating(s).

  • GRFS’s FA Score: 1 green, 4 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, GRFS is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRFS’s TA Score shows that 4 TA indicator(s) are bullish while SNY’s TA Score has 4 bullish TA indicator(s).

  • GRFS’s TA Score: 4 bullish, 5 bearish.
  • SNY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNY is a better buy in the short-term than GRFS.

Price Growth

GRFS (@Pharmaceuticals: Major) experienced а +3.59% price change this week, while SNY (@Pharmaceuticals: Major) price change was +3.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.73%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +5.45%.

Reported Earning Dates

GRFS is expected to report earnings on Nov 10, 2026.

SNY is expected to report earnings on Oct 30, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+0.73% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
GRFS
Daily Signal:
Gain/Loss:
SNY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

GRFS and

Correlation & Price change

A.I.dvisor tells us that GRFS and SNY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRFS and SNY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRFS
1D Price
Change %
GRFS100%
-0.67%
SNY - GRFS
29%
Poorly correlated
+2.42%
GSK - GRFS
28%
Poorly correlated
+2.38%
GILD - GRFS
28%
Poorly correlated
+2.36%
NVS - GRFS
28%
Poorly correlated
+1.52%
BMY - GRFS
27%
Poorly correlated
+3.08%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with PFE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+2.42%
PFE - SNY
47%
Loosely correlated
+1.91%
JNJ - SNY
36%
Loosely correlated
+3.81%
MRK - SNY
35%
Loosely correlated
-1.76%
AMGN - SNY
35%
Loosely correlated
+2.04%
GILD - SNY
34%
Loosely correlated
+2.36%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FGSM34.15-0.18
-0.53%
Frontier Asset Global Small-Cap Equity ETF
IPKW59.67-0.37
-0.61%
Invesco International BuyBack Achievers ETF (IPKW)
DFE73.85-0.68
-0.91%
WisdomTree Europe SmallCap Dividend Fund (DFE)
DEM53.87-0.92
-1.68%
WisdomTree Emerging Markets High Dividend Fund (DEM)
POEL3.60-0.50
-12.20%
Defiance Daily Target 2X Long POET ETF